Therapies for the treatment of rare pulmonary diseases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
56
NCT06659757
A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 16, 2024
Completion: Jul 14, 2025
Loading map...